AZD 2066
99%
- Product Code: 52599
CAS:
934282-55-0
| Molecular Weight: | 381.82 g./mol | Molecular Formula: | C₁₉H₁₆ClN₅O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22420281 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
AZD 2066 is primarily investigated for its potential therapeutic applications in the field of medicine, particularly in the treatment of chronic pain conditions. It functions as a selective inhibitor of fatty acid amide hydrolase (FAAH), an enzyme responsible for breaking down endocannabinoids in the body. By inhibiting FAAH, AZD 2066 increases the levels of these endocannabinoids, which play a role in modulating pain and inflammation. This mechanism makes it a promising candidate for managing conditions such as osteoarthritis and neuropathic pain, where traditional pain relief methods may be insufficient. Clinical trials have explored its efficacy and safety profile, aiming to provide an alternative treatment option for patients suffering from persistent pain. Its development highlights the growing interest in targeting the endocannabinoid system for therapeutic purposes.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿57,042.00 |
+
-
|
AZD 2066
AZD 2066 is primarily investigated for its potential therapeutic applications in the field of medicine, particularly in the treatment of chronic pain conditions. It functions as a selective inhibitor of fatty acid amide hydrolase (FAAH), an enzyme responsible for breaking down endocannabinoids in the body. By inhibiting FAAH, AZD 2066 increases the levels of these endocannabinoids, which play a role in modulating pain and inflammation. This mechanism makes it a promising candidate for managing conditions such as osteoarthritis and neuropathic pain, where traditional pain relief methods may be insufficient. Clinical trials have explored its efficacy and safety profile, aiming to provide an alternative treatment option for patients suffering from persistent pain. Its development highlights the growing interest in targeting the endocannabinoid system for therapeutic purposes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :